top of page
IP & Publication
Investors & News
Use tab to navigate through the menu items.
TIMEBIO is developing multi-target recombinant exosome-based biomedicine to reverse aging and diseases using our proprietary DLC(Dynamic Link Cell) and ExDLL exosome engineering platform.
bottom of page